Filing Details
- Accession Number:
- 0001127602-12-013514
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-09 17:55:53
- Reporting Period:
- 2012-04-05
- Filing Date:
- 2012-04-09
- Accepted Time:
- 2012-04-09 16:55:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222114 | J Joseph Corasanti | 101 Winship Road New Hartford NY 13413 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-05 | 15,000 | $17.74 | 92,161 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-05 | 15,000 | $30.25 | 77,161 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2012-04-05 | 15,000 | $0.00 | 15,000 | $17.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,491 | 2013-05-20 | No | 4 | M | Direct |
Footnotes
- 5 year vesting schedule, 20% vest each year starting 5/20/2004.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.41. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2012.
Billionaire Hedge Funds
